JA
GHDX

JOYN Advisors’s Genomic Health, Inc. GHDX Stock Holding History

JOYN Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-307
Closed -$20K – 1694
2018
Q4 		$20K Sell
307
-790
-72% -$55.4K ﹤0.01% 680
2018
Q3 		$77K Sell
1,097
-339
-24% -$19.8K 0.01% 277
2018
Q2 		$72K Sell
1,436
-2,244
-61% -$89K 0.02% 305
2018
Q1 		$115K Buy
+3,680
New +$122K 0.02% 229

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JOYN Advisors's GHDX Position: Q1 2019 in Review

JOYN Advisors sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 307 shares — an estimated $20K sold.

JOYN Advisors first reported a position in GHDX in Q1 2018 and held it in 4 quarters. The position peaked at $115K in Q1 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • JOYN Advisors reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 307 Genomic Health, Inc. shares in Q1 2019, an estimated $20K.
  • JOYN Advisors first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Genomic Health, Inc. position peaked at $115K in Q1 2018.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.